1. Home
  2. TGL vs PULM Comparison

TGL vs PULM Comparison

Compare TGL & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$4.77

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$2.97

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
PULM
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
9.4M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
TGL
PULM
Price
$4.77
$2.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.6K
12.4K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
$2,330,557.00
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.04
$2.15
52 Week High
$58.00
$9.37

Technical Indicators

Market Signals
Indicator
TGL
PULM
Relative Strength Index (RSI) 44.86 61.87
Support Level $4.51 $2.25
Resistance Level $9.45 $4.97
Average True Range (ATR) 0.46 0.19
MACD 0.05 0.08
Stochastic Oscillator 46.43 76.83

Price Performance

Historical Comparison
TGL
PULM

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: